Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:adenosine_receptor_antagonist
gptkb:chemical_compound |
| gptkbp:CASNumber |
120342-14-5
|
| gptkbp:effect |
antagonist at adenosine A2A receptor
inhibits adenosine-induced cAMP accumulation modulates dopaminergic neurotransmission potential neuroprotective effects in models of Parkinson's disease |
| gptkbp:hasMolecularFormula |
C17H16N8O2
|
| gptkbp:hasRole |
research chemical
pharmacological tool |
| gptkbp:is_selective_for |
adenosine A2A receptor over A1 receptor
|
| gptkbp:IUPACName |
4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol
|
| gptkbp:molecularWeight |
364.36 g/mol
|
| gptkbp:PubChem_CID |
5311106
CHEMBL23356 |
| gptkbp:synonym |
gptkb:ZM_241385
4-(2-[7-amino-2-(furan-2-yl)-[1,2,4]triazolo[1,5-c]pyrimidin-5-ylamino]ethyl)phenol |
| gptkbp:target |
gptkb:adenosine_A2A_receptor
|
| gptkbp:used_in |
gptkb:scientific_research
|
| gptkbp:bfsParent |
gptkb:CHEMBL1173605
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
ZM241385
|